Inicio>>Signaling Pathways>> Neuroscience>> Dopamine Receptor>>UCM-1306

UCM-1306 (Synonyms: 2-(Fluoromethoxy)-4'-(S-methylsulfonimidoyl)-1,1'-biphenyl)

Catalog No.GC70086

UCM-1306 es un modulador alostérico positivo (PAM) de los receptores D1 de dopamina oralmente efectivo. UCM-1306 aumenta el máximo efecto endógeno de la dopamina en los receptores D1 humanos y de ratón. Además de mejorar los síntomas motores, UCM-1306 también aborda las comorbilidades cognitivas clave asociadas con la enfermedad de Parkinson (PD) a largo plazo.

Products are for research use only. Not for human use. We do not sell to patients.

UCM-1306 Chemical Structure

Cas No.: 2258608-78-3

Tamaño Precio Disponibilidad Cantidad
10mg
216,00 $
Disponible
25mg
441,00 $
Disponible
50mg
702,00 $
Disponible
100mg
1.125,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Reseñas

Review for UCM-1306

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for UCM-1306

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.